Response to Letter by Moll regarding article, "hemostatic therapy in experimental intracerebral hemorrhage associated with the direct thrombin inhibitor dabigatran"

Stroke

Volumn 43, Issue 2, 2012, Pages

  Zhou, Wei ^a   Veltkamp, Roland ^a   Schwarting, Sönke ^a   Illanes, Sergio ^a   Liesz, Arthur ^a   Middelhoff, Moritz ^a   Zorn, Markus ^a   Bendszus, Martin ^a   Heiland, Sabine ^a   Van Ryn, Joanne ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; DABIGATRAN ETEXILATE; PROTHROMBIN COMPLEX; WARFARIN;

ANTICOAGULANT THERAPY; BLEEDING TIME; BRAIN HEMORRHAGE; CLINICAL STUDY; CLINICAL TRIAL (TOPIC); HEART ATRIUM FIBRILLATION; HEMATOMA; HEMOSTASIS; HUMAN; LETTER; MEDICAL DOCUMENTATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; STROKE;

EID: 84856508153     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.643809     Document Type: Letter

References (6)

1. Moll S. Letter by Moll regarding article, "hemostatic therapy in experimental intracerebral hemorrhage associated with the direct thrombin inhibitor dabigatran." Stroke. 2012;43:e24.
2. Lauer A, Cianchetti FA, Van Cott EM, Schlunk F, Schulz E, Pfeilschifter W, et al. Anticoagulation with the oral direct thrombin inhibitor dabigatran does not enlarge hematoma volume in experimental intracerebral hemorrhage/clinical perspective. Circulation. 2011;124:1654-1662.
3. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361:1139-1151.
4. Eerenberg ES, Kamphuisen PW, Sijpkens MK, Meijers JC, Buller HR, Levi M. Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: A randomized, placebo-controlled, crossover study in healthy subjects. Circulation. 2011;124:1573-1579.
5. van Ryn J, Schurer J, Kink-Eiband M, Clemens A. The successful reversal of dabigatran-induced bleeding by coagulation factor concentrates in a rat tail bleeding model do not correlate with ex vivo markers of anticoagulation (Abstract 2316). In: 53rd Annual Meeting and Exposition of American Society of Hematology; December 10-13, 2011; San Diego, CA.
6. Flibotte JJ, Hagan N, O'Donnell J, Greenberg SM, Rosand J. Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage. Neurology. 2004;63:1059-1064. (Pubitemid 39287915)